journal article·2018-06

Generation of versatile titania-silica nano-vehicles using dual templates exploiting as tunable drug releaser

Mahboubeh Habibi, Hamid Reza Aghabozorg, Aliakbar Tarlani

Publisher page

Abstract

Abstract In a new approach, a series of nanoporous TiO2-SiO2 systems (NTSn (n = 1–5)) were synthesized with various Ti/Si ratios via one step hydrothermal process in the presence of P123 and tetrabutylammonium bromide (TBAB) as dual templating agents. Then, simvastatin (SV) as a model drug was incorporated into the prepared mesoporous matrixes (NTS@SV). Wide-angle X-ray diffraction data (WAXRD), Fourier transform infrared spectroscopy (FT-IR), Raman spectroscopy, N2 adsorption-desorption isotherms, field emission scanning electron microscopy (FE-SEM), energy-dispersive X-ray spectroscopy (EDS), transmission electron microscopy (TEM) and zeta potential (ζ) measurement were used for the characterization of the prepared samples. It was found that the variation of Ti percent and attendance of both TBAB & P123 in the synthesis condition led to high pore volume (0.6–1.2 cm3 g-1), high surface area (187–656 m2 g-1), a wide range of pore sizes (5–13 nm) and surface zeta potential charge (−16 to −24 mV) of the prepared samples. These diversities made wide opportunities for new NTS@SV to exhibit the vast drug-release profiles in simulated gastric fluid (SGF, pH = 1.2) and simulated intestinal fluid (SIF, pH = 6.8) at 37 °C. In vitro drug release indicated that the sample prepared in the presence of both TBAB and P123 with Ti/Si = 1 represented maximum release of SV (ζ = −18 mV) equal to 77 and 100% in SGF and SIF media, respectively. SH-SY5Y cell viability was tested against the toxic background of parkinsonian toxin 6-OHDA upon cell exposure to NTS3@SV. Results demonstrated cell exposure to NTS3@SV neutralized 6-OHDA toxicity and enhanced cell survival significantly.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Mesoporous Materials and Catalysis · Metal-Organic Frameworks: Synthesis and Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (74)

Show source-provided references
1. Functionalized mesoporous silica materials for controlled drug delivery10.1039/c2cs15308d ↗
2. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging10.1038/nmat2608 ↗
3. Construction of magnetic-targeted and NIR irradiation-controlled drug delivery platform with Fe 3 O 4 @Au@SiO 2 nanospheres10.1016/j.ceramint.2017.01.017 ↗
4. Controllable release of ibuprofen from size-adjustable and surface hydrophobic mesoporous silica spheres10.1016/j.powtec.2008.09.001 ↗
5. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release10.1002/asia.201301105 ↗
6. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery10.1002/adma.201104763 ↗
7. PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles10.1016/j.micromeso.2010.11.013 ↗
8. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate10.1016/j.msec.2013.08.014 ↗
9. Enhanced release and drug delivery of celecoxib into physiological environment by the different types of nanoscale vehicles10.1016/j.apsusc.2017.06.010 ↗
10. Facile, low-cost, and organic-free fabrication of diverse nanoporous alumina as support for drug release; on the salt effect, calcination temperature, and reaction time dependence
11. Coordination polymer coated mesoporous silica nanoparticles for ph-responsive drug release10.1002/adma.201201742 ↗
12. Mesoporous materials for drug delivery10.1002/anie.200604488 ↗
13. Mesoporous silica nanoparticles in medicine — recent advances10.1016/j.addr.2012.07.018 ↗
14. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica10.1016/j.jcis.2017.03.021 ↗
15. Amine-modified mesoporous silica for CO 2 adsorption: the role of structural parameters10.1021/acs.iecr.7b00890 ↗
16. Versatile drug releaser derived from the Ti-substituted mesoporous silica SBA-1510.1016/j.micromeso.2014.08.005 ↗
17. Ordered mesoporous silica and aluminosilicate-type matrix for amikacin delivery systems10.1016/j.micromeso.2013.08.018 ↗
18. Tailoring morphological and interfacial properties of diatom silica microparticles for drug delivery applications10.1016/j.apt.2013.03.015 ↗
19. Single and networked ZnO–CNT hybrid tetrapods for selective room-temperature high-performance ammonia sensors10.1021/acsami.7b03702 ↗
20. Self-assembly approach for the synthesis of electro-magnetic functionalized Fe3O4/polyaniline nanocomposites: effect of dopant on the properties10.1016/j.colsurfa.2007.12.057 ↗
21. Synthesis and characterization of core-shell SiO 2 nanoparticles/poly (3-aminophenylboronic acid ) composites10.1002/app.25938 ↗
22. Facile fabrication and photocatalytic application of Ag nanoparticles-TiO2 nanofiber composites10.1166/jnn.2011.3805 ↗
23. Carbon functionalized TiO 2 nanofibers for high efficiency photocatalysis10.1088/2053-1591/1/1/015012 ↗
24. A new one-step synthesis method for coating multi-walled carbon nanotubes with cuprous oxide nanoparticles10.1016/j.scriptamat.2008.01.047 ↗
25. Multiple functionalization of SBA-15 mesoporous silica in one-pot: fabricating an aluminum-containing plugged composite for sustained heparin release10.1039/c3tb20425a ↗
26. Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion10.1016/j.actbio.2011.09.004 ↗
27. Effect of textural properties on the drug delivery behaviour of nanoporous TiO2 matrices10.1016/j.micromeso.2010.10.042 ↗
28. Development of an amorphous mesoporous TiO2 nanosphere as a novel Carrier for poorly water-soluble drugs: effect of different crystal forms of TiO2 carriers on drug loading and release behaviors10.1016/j.micromeso.2011.12.013 ↗
29. TiO2 nanocrystals grafted on macroporous silica: a novel hybrid organic-inorganic sol-gel approach for the synthesis of highly photoactive composite material10.1016/j.apcatb.2011.03.018 ↗
30. Peptization technique in the synthesis of titania-silica composites and their photocatalytic properties10.1016/j.cej.2012.05.026 ↗
31. Titania-containing mesoporous silica powders: structural properties and photocatalytic activity towards isopropanol degradation10.1016/j.jphotochem.2010.07.011 ↗
32. An investigation into the effect of porosities on the adsorption of rhodamine B using titania-silica mixed oxide xerogels
33. Enhanced bioavailability and hypolipidemic activity of Simvastatin formulations by particle size engineering: physicochemical aspects and in vivo investigations10.1016/j.bej.2013.08.007 ↗
34. Performance evaluation of PAMAM dendrimer based simvastatin formulations10.1016/j.ijpharm.2010.12.002 ↗
35. F loating matrix tablets based on low density foam powder : effects of formulation and processing parameters on drug release10.1016/S0928-0987(02)00223-3 ↗
36. Development of simvastatin electrospun fibers: a novel approach for sustained drug delivery10.1007/s40005-014-0140-5 ↗
37. Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties10.1016/j.ijpharm.2010.07.040 ↗
38. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs10.1016/j.msec.2014.08.040 ↗
39. Methylene blue photodegradation over titania-decorated SBA-1510.1016/j.apcatb.2011.08.032 ↗
40. Synthesis of highly hydrophobic rutile titania-silica nanocomposites by an improved hydrolysis co-precipitation method10.1016/j.ceramint.2017.01.091 ↗
41. What is modulating solubility in simulated intestinal fluids?10.1016/j.ejps.2010.07.012 ↗
42. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine10.1016/j.msec.2014.10.067 ↗
43. Physisorption of gases, with special reference to the evaluation of surface area and pore size distribution (IUPAC Technical Report)10.1515/pac-2014-1117 ↗
44. Hydrothermal synthesis and morphological evolution of mesoporous titania-silica10.1021/jp9037842 ↗
45. A new property of MCM-41:drug delivery system10.1021/cm0011559 ↗
46. Tailoring pore size of ordered mesoporous silicas using one or two organic auxiliaries as Expanders.pdf10.1021/la020042w ↗
47. Synthesis of large-pore face-centered-cubic periodic mesoporous organosilicas with unsaturated bridging groups10.1016/j.micromeso.2015.10.017 ↗
48. Microporous titania-silica nanocomposite catalyst-adsorbent for ultra-deep oxidative desulfurization10.1016/j.apcatb.2015.06.011 ↗
49. Influence of structural, textural and surface properties of mesostructured silica and aluminosilicate carriers on aminoglycoside uptake and in vitro delivery10.1016/j.micromeso.2014.12.022 ↗
50. Synthesis of thermally stable and highly ordered bicontinuous cubic mesoporous titania-silica binary oxides with crystalline framework10.1016/j.micromeso.2009.05.019 ↗
51. The synthesis of mesoporous TiO2/SiO2/Fe2 O3 hybrid particles containing micelle- induced macropores through an aerosol based process10.1021/la105149p ↗
52. Microporous titania-silica nanocomposite catalyst-adsorbent for ultra-deep oxidative desulfurization10.1016/j.apcatb.2015.06.011 ↗
53. Comparative study of sol-gel-hydrothermal and sol-gel synthesis of titania-silica composite nanoparticles10.1016/j.jssc.2004.12.034 ↗
54. Environmental Methylene blue photodegradation over titania-decorated SBA-1510.1016/j.apcatb.2011.08.032 ↗
55. Titania–silica as catalysts: molecular structural characteristics and physico-chemical properties10.1016/S0920-5861(99)00048-6 ↗
56. Design, synthesis, fabrication and in vitro evalution of mucoadhesive 5-amino-2-mercaptobenzimidazole chitosan as low water soluble drug carriers10.1016/j.ejpb.2014.08.016 ↗
57. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug10.1016/j.jcis.2011.07.022 ↗
58. Synthesis and biological response of casein-based silica nano-composite film for drug delivery system10.1016/j.colsurfb.2013.06.011 ↗
59. Preparation and characterization of monodisperse porous silica microspheres with controllable morphology and structure10.1002/pola.26066 ↗
60. Nanoscale assembly of mesoporous ZnO: a potential drug carrier10.1039/c0jm00022a ↗
61. Quantum dots conjugated with Fe3O4-filled carbon nanotubes for cancer-targeted imaging and magnetically guided drug delivery10.1021/la303957y ↗
62. Synthesis of nanostructured alumina with ultrahigh pore volume for pH-dependent release of curcumin10.1039/C7RA03231E ↗
63. Facile synthesis of functionalized ionic surfactant templated mesoporous silica for incorporation of poorly water-soluble drug10.1016/j.ijpharm.2015.07.014 ↗
64. Surface phases of TiO2 nanoparticles studied by UV Raman spectroscopy and FT-IR spectroscopy10.1021/jp7118422 ↗
65. Precise size control over ultrafine rutile titania nanocrystallites in hierarchical nanotubular silica/titania hybrids with efficient photocatalytic activity10.1002/chem.201300649 ↗
66. Cosolvent-induced gelation and the hydrothermal enhancement of the crystallinity of titania-silica mixed oxides for the photocatalytic remediation of organic pollutants10.1021/jp110988j ↗
67. Methylene blue photodegradation over titania-decorated SBA-1510.1016/j.apcatb.2011.08.032 ↗
68. Synthesis of titania – silica mixed oxide mesoporous materials
69. SBA-15 mesoporous material modified with APTES as the carrier for 2-(3-benzoylphenyl)propionic acid10.1016/j.apsusc.2012.04.076 ↗
70. Indometacin loading and in vitro release properties from novel carbopol coated spherical mesoporous silica nanoparticles10.1016/j.micromeso.2012.12.037 ↗
71. Fibrous growth of strontium substituted hydroxyapatite and its drug release10.1016/j.msec.2010.11.025 ↗
72. Influence of the structural and textural properties of ordered mesoporous materials and hierarchical zeolitic supports on the controlled release of methylprednisolone hemisuccinate10.1039/C4TB00089G ↗
73. Controlled pH- and glucose-responsive drug release behavior of cationic chitosan based nano-composite hydrogels by using graphene oxide as drug nanocarrier10.1016/j.jiec.2016.12.023 ↗
74. Drug release profiles of modified MCM-41 with superparamagnetic behavior correlated with the employed synthesis method10.1016/j.msec.2017.02.010 ↗